THE COMBINED EFFECT OF 1,25(OH)2D3 WITH CBP OR IONIZING RADIATION ON THE PROLIFERATION OF OVARIAN CANCER SKOV-3 CELLS

被引：0
|
作者：
Hu, Zhiyong [1 ]
Zhang, Zengli [1 ]
Li, Bingyan [1 ]
机构：
[1] Soochow Univ, Sch Radiat Med & Publ Hlth, Suzhou, Peoples R China
来源：
ANTICANCER RESEARCH | 2011年 / 31卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
15
引用
收藏
页码：1495 / 1496
页数：2
相关论文
共 50 条
  • [1] 1α,25(OH)2D3 Suppresses the Migration of Ovarian Cancer SKOV-3 Cells through the Inhibition of Epithelial-Mesenchymal Transition
    Hou, Yong-Feng
    Gao, Si-Hai
    Wang, Ping
    Zhang, He-Mei
    Liu, Li-Zhi
    Ye, Meng-Xuan
    Zhou, Guang-Ming
    Zhang, Zeng-Li
    Li, Bing-Yan
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (08):
  • [2] THE EFFECT OF 1,25(OH)2D3 ON THE CYTOSKELETON OF OSTEOBLASTIC CELLS
    GRONOWICZ, G
    EGAN, JJ
    RODAN, GA
    JOURNAL OF CELL BIOLOGY, 1984, 99 (04): : A427 - A427
  • [3] EFFECT OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON EXPERIMENTAL RICKETS
    KRAFT, D
    OFFERMANN, G
    STELDINGER, R
    GAWLIK, D
    RESEARCH COMMUNICATIONS IN CHEMICAL PATHOLOGY AND PHARMACOLOGY, 1979, 26 (03): : 571 - 580
  • [4] 24,25(OH)2D3 ENHANCES THE CALCEMIC EFFECT OF 1,25(OH)2D3
    WALD, H
    HAYEK, T
    POPOVTZER, MM
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1985, 180 (02): : 219 - 223
  • [5] PRODUCTION OF 24,25(OH)2D3 AND 1,25(OH)2D3 BY HUMAN FORESKIN KERATINOCYTES - REGULATION BY 1,25(OH)2D3
    NEMANIC, M
    BIKLE, D
    FEDERATION PROCEEDINGS, 1983, 42 (05) : 1178 - 1178
  • [6] GONADAL 1,25(OH)2D3 RECEPTOR AND ACTION OF 1,25(OH)2D3 ON LH STIMULATED TESTICULAR AND OVARIAN CAMP RESPONSE
    MERKE, J
    KREUSSER, W
    RITZ, E
    JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1982, 17 (03): : R111 - R111
  • [7] EFFECT OF 1,25(OH)2D3 AND 24,25(OH)2D3 ON CALCIUM FLUXES INVITRO
    SCHWARTZ, Z
    LANGSTON, GG
    BOYAN, BD
    JOURNAL OF DENTAL RESEARCH, 1989, 68 (04) : 657 - 657
  • [8] 1,25(OH)2D3 AND 25-OHD3 IN THE TREATMENT OF RENAL OSTEODYSTROPHY - COMPARISON OF COMBINED VERSUS 1,25(OH)2D3 ADMINISTRATION ALONE
    COEN, G
    GALLUCCI, MT
    BONUCCI, E
    BALLANTI, P
    BIANCHI, AR
    BIANCHINI, G
    MATTEUCCI, MC
    MAZZAFERRO, S
    PICCA, S
    TAGGI, F
    CINOTTI, GA
    CASCIANI, CU
    MINERAL AND ELECTROLYTE METABOLISM, 1983, 9 (01) : 19 - 27
  • [9] Combined action of menadione and 1,25(OH)2D3 in reducing human breast cancer cell proliferation
    Picotto, G.
    Marchionatti, A. M.
    Narvaez, C. J.
    Welsh, JoE
    Tolosa de Talamoni, N.
    BONE, 2007, 40 (03) : S5 - S5
  • [10] THE GONADS ARE TARGET ORGANS FOR 1,25(OH)2D3 DEMONSTRATION OF 1,25(OH)2D3 RECEPTORS AND IMPAIRED CAMP RESPONSE IN 1,25(OH)2D3 DEFICIENCY STATE (NX)
    MERKE, J
    KREUSSER, W
    RITZ, E
    ACTA ENDOCRINOLOGICA, 1983, 102 : 27 - 27
12345